Narrated by actor Manoj Bajpayee, the 60-minute documentary traces India’s journey from deciding to develop a vaccine on its own to becoming the world’s saviour by providing the jabs to several countries
CEPI will fund the researchers to conduct activities including immunogen design, preclinical studies, manufacturing process development and a Phase 1 clinical trial.
In an interview, Bharat Biotech chairman Dr Krishna Ella said phase 3 clinical trials of the non-invasive, needle-free vaccine are on, and the initial results are promising
Several facets of our great nation were brought forth by the sudden impact of COVID-19. For one, healthcare infrastructure and diagnostics need fundamental changes and strategic direction for future improvement. Vaccinology has, however, written success stories in both development and manufacturing. It also highlighted how public-private partnership can succeed, building on the nation’s earlier success with developing and manufacturing world-class Rotavirus vaccine ROTAVAC, TYPBAR TCV, the innovator Typhoid Conjugate Vaccine among other world-leading vaccines. These challenging times also reaffirmed the growing need to nurture startups in areas of vaccine development and the ever-increasing need for the industry and academia to participate in advancing science.